Skip to Main Content

SILK

SILK Real Time Price USD
N/A
N/A
N/A
Price Data Unavailable for SILK
Add to Watchlist
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of SILK by members of U.S. Congress

SILK Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
SILK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SILK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Whales0.3333333333New0Increased0Held1Decreased0Closed0

Quarterly net insider trading by SILK's directors and management

2024Q22024Q32024Q42025Q12025Q2−2000−1500−1000−5000
Net Shares Purchased by Insiders

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

SILK Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
SILK Income Statement
SILK Balance Sheet
SILK Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Suture delivery device Mar. 11, 2025
  • Patent Title: Systems and methods for transcatheter aortic valve treatment Feb. 11, 2025
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 14, 2025
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 14, 2025
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Dec. 03, 2024
  • Patent Title: Systems and methods for treating a carotid artery Dec. 03, 2024
  • Patent Title: Methods and systems for treatment of acute ischemic stroke Nov. 19, 2024
  • Patent Title: Systems and methods for treating a carotid artery Oct. 29, 2024
  • Patent Title: Methods and devices for transcarotid access Aug. 06, 2024
  • Patent Title: Endoluminal delivery of anesthesia Aug. 06, 2024
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jul. 23, 2024
  • Patent Title: Vessel access and closure assist system and method Jul. 09, 2024
  • Patent Title: Method and apparatus for treating an arterial lesion Mar. 05, 2024
  • Patent Title: Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization Jan. 09, 2024
  • Patent Title: Systems and methods for aspirating from a body lumen Jan. 02, 2024
  • Patent Title: Method and apparatus for treating an arterial lesion Dec. 26, 2023
  • Patent Title: Suture delivery device Dec. 12, 2023
  • Patent Title: Methods and devices for transcarotid access Sep. 19, 2023
  • Patent Title: Methods and systems for treatment of acute ischemic stroke May. 23, 2023
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Sep. 06, 2022
  • Patent Title: Suture delivery device Jul. 19, 2022
  • Patent Title: Interventional catheter system and methods Jun. 21, 2022
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jun. 21, 2022
  • Patent Title: Transcarotid neurovascular catheter Apr. 05, 2022
  • Patent Title: Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization Oct. 12, 2021
  • Patent Title: Methods and systems for treatment of acute ischemic stroke Aug. 31, 2021
  • Patent Title: Devices and methods for endoluminal delivery of either fluid or energy for denervation Aug. 24, 2021
  • Patent Title: Methods and devices for transcarotid access Jun. 08, 2021
  • Patent Title: Vessel access and closure assist system and method Apr. 13, 2021
  • Patent Title: Systems and methods for treating a carotid artery Mar. 23, 2021
  • Patent Title: Systems and methods for aspirating from a body lumen Mar. 09, 2021
  • Patent Title: Systems and methods for transcatheter aortic valve treatment Feb. 23, 2021
  • Patent Title: Vascular implant Feb. 16, 2021
  • Patent Title: Suture delivery device Jan. 05, 2021
  • Patent Title: Methods and devices for transcarotid access Dec. 15, 2020
  • Patent Title: Endoluminal delivery of anesthesia Nov. 10, 2020
  • Patent Title: Method and apparatus for treating a carotid artery Sep. 22, 2020
  • Patent Title: Method and apparatus for treating an arterial lesion Jul. 28, 2020
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jul. 14, 2020
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Jan. 28, 2020
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Nov. 26, 2019
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Oct. 01, 2019
  • Patent Title: Systems and methods for aspirating from a body lumen Aug. 27, 2019
  • Patent Title: Transcarotid neurovascular catheter Aug. 20, 2019
  • Patent Title: Systems and methods for treating a carotid artery Aug. 06, 2019
  • Patent Title: Suture delivery device Jul. 23, 2019
  • Patent Title: Endoluminal delivery of anesthesia Jun. 25, 2019
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow May. 14, 2019
  • Patent Title: Devices and methods for endoluminal delivery of either fluid or energy for denervation Apr. 30, 2019
  • Patent Title: Methods and systems for establishing retrograde carotid arterial blood flow Mar. 26, 2019
Government Contracts

Estimated quarterly amount awarded from public contracts

20212022202320242025020k40k60k80k100k120k140k
Q4Q3Q2Q1Government Contracts Amount
SILK News

Recent insights relating to SILK

Quiver QuantitativeNew Insider Disclosure: Klemz Kevin M (EVP/Chief Legal Officer/Sec.) disclosed 2268 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 66 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Ruedy Richard (EVPClin&Reg.Affairs&QA) disclosed 3800 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Buchanan Lucas W. (COO/CFO) disclosed 9877 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 5481 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Klemz Kevin M (EVP/Chief Legal Officer/Sec.) disclosed 2497 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Jones Marie L. (VP, Finance and CAO) disclosed 2602 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Ruedy Richard (EVPClin&Reg.Affairs&QA) disclosed 3000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Jones Marie L. (CAO and VP, Finance) disclosed 656 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 1000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 3000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 6753 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 6000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 6753 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 6000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 3868 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Buchanan Lucas W. (COO/CFO) disclosed 9918 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 18043 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Ruedy Richard (EVPClin&Reg.Affairs&QA) disclosed 2373 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 6753 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 6000 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Davis Andrew S. (Chief Commercial Officer) disclosed 6753 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Buchanan Lucas W. (COO/CFO) disclosed 86244 shares sold of $SILKArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Rogers Erica J. (President and CEO) disclosed 6000 shares sold of $SILKArticle Thumbnail
CNBC Recommendations

Recent picks made for SILK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SILK

SILK Analyst Ratings

SILK Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
SILK Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $SILK stock a Buy, Sell, or Hold?

  • What is the price target for $SILK stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

SILK Top Shareholders
Shareholder
Shares Held
SILK Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $SILK stock?

  • Who owns the most shares of $SILK stock?

  • What funds own $SILK stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SILK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SILK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Bull Case vs Bear Case data is only available to Quiver Premium subscribers.

Back To Top